| ARDIZZONI, Andrea, Evangelia RAZIS, Mikhail LICHINITSER, Ugur YILMAZ, Alexandru GRIGORESCU, Jusé Luis MORERO, Jana SKŘIČKOVÁ, Guadalupe CERVANTES, Maya GOTTFRIED and Jan VAN MEERBEECK. Interim safety results from TRUST, a global open-label study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC). In Journal of Thoracic Oncology. Seoul , Korea: Journal of Thoracic Oncology, 2007, p. 342-342. ISSN 1556-0864. |
Other formats:
BibTeX
LaTeX
RIS
@inproceedings{724768,
author = {Ardizzoni, Andrea and Razis, Evangelia and Lichinitser, Mikhail and Yilmaz, Ugur and Grigorescu, Alexandru and Morero, Jusé Luis and Skřičková, Jana and Cervantes, Guadalupe and Gottfried, Maya and Van Meerbeeck, Jan},
address = {Seoul , Korea},
booktitle = {Journal of Thoracic Oncology},
keywords = {Erlotinib; non-small cell lung cancer; drug safety; TRUST study},
language = {eng},
location = {Seoul , Korea},
pages = {342-342},
publisher = {Journal of Thoracic Oncology},
title = {Interim safety results from TRUST, a global open-label study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC).},
year = {2007}
}
TY - JOUR
ID - 724768
AU - Ardizzoni, Andrea - Razis, Evangelia - Lichinitser, Mikhail - Yilmaz, Ugur - Grigorescu, Alexandru - Morero, Jusé Luis - Skřičková, Jana - Cervantes, Guadalupe - Gottfried, Maya - Van Meerbeeck, Jan
PY - 2007
TI - Interim safety results from TRUST, a global open-label study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC).
PB - Journal of Thoracic Oncology
CY - Seoul , Korea
KW - Erlotinib
KW - non-small cell lung cancer
KW - drug safety
KW - TRUST study
N2 - An international group of authors have published interim results concerning the drug safety of erlotinib, an anti-tumor drug used in treatment of patients with advanced non-small cell lung cancer within TRUST, a global open-label study of erlotinib.
ER -
ARDIZZONI, Andrea, Evangelia RAZIS, Mikhail LICHINITSER, Ugur YILMAZ, Alexandru GRIGORESCU, Jusé Luis MORERO, Jana SKŘIČKOVÁ, Guadalupe CERVANTES, Maya GOTTFRIED and Jan VAN MEERBEECK. Interim safety results from TRUST, a global open-label study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC). In \textit{Journal of Thoracic Oncology}. Seoul , Korea: Journal of Thoracic Oncology, 2007, p.~342-342. ISSN~1556-0864.
|
